The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of intra-tumoral microbiome and response to immune checkpoint inhibitors (ICIs) in patients with metastatic renal cell carcinoma (mRCC).
 
Luis A Meza
No Relationships to Disclose
 
Yongwook Choi
No Relationships to Disclose
 
Ameish Govindarajan
No Relationships to Disclose
 
Nazli Dizman
Consulting or Advisory Role - Vivreon Biosciences
 
Zeynep Busra Zengin
No Relationships to Disclose
 
Joann Hsu
No Relationships to Disclose
 
Nicholas Salgia
No Relationships to Disclose
 
Sabrina Salgia
No Relationships to Disclose
 
Jasnoor Malhotra
No Relationships to Disclose
 
Neal Shiv Chawla
No Relationships to Disclose
 
Alex Chehrazi-Raffle
No Relationships to Disclose
 
Ramya Muddasani
Stock and Other Ownership Interests - Abbvie; Abbvie; Actinium Pharmaceuticals; Actinium Pharmaceuticals (I); Advaxis (I); Agenus; Agenus (I); Aprea Therapeutics; Aprea Therapeutics (I); Athenex (I); AVEO (I); Cellectar; Cellectar (I); crispr therapeutics (I); Curis (I); DelMar Pharmaceuticals; DelMar Pharmaceuticals (I); DelMar Pharmaceuticals (I); Epizyme; Epizyme (I); Forty Seven; Forty Seven (I); Gritstone Bio (I); Heat Biologics (I); Immunomedics; Immunomedics (I); Mereo BioPharma (I); NantHealth (I); NantKwest,; NantKwest, (I); Novavax (I); Onconova Therapeutics; Onconova Therapeutics (I); Pfizer (I); Portola Pharmaceuticals (I); Vaxart
 
Daniela V. Castro
No Relationships to Disclose
 
Agnes Chan
No Relationships to Disclose
 
Guangfa Zhang
No Relationships to Disclose
 
Sara A. Byron
No Relationships to Disclose
 
Sarah K Highlander
No Relationships to Disclose
 
Nick Schork
No Relationships to Disclose
 
Sumanta K. Pal
Consulting or Advisory Role - F. Hoffmann LaRoche; F. Hoffmann LaRoche; Roche
Research Funding - Eisai (Inst); Exelixis (Inst); Genentech (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Genentech; Seagen